Top Markets
#1 Threshold Network Threshold Network +48.26%
#2 TENDIES TENDIES +47.46%
#3 Mubarak Mubarak +19.04%
#4 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#5 OSK OSK +16.18%
#6 Kinetiq Kinetiq +15.12%
#7 Ape and Pepe Ape and Pepe +12.62%
#8 MultiversX MultiversX +11.47%
#9 Maple Finance Maple Finance +11.12%
#10 Magma Finance Magma Finance +10.48%
Coin of the day
Threshold Network Threshold Network
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA
Pozycja w akcjach #17294
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company... Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Cena akcji
$1.38
Kapitalizacja rynkowa
$255.69M
Zmiana (1 dzień)
3.76%
Zmiana (1 rok)
-20.69%
Kraj
US
Handel Neumora Therapeutics, Inc. Common Stock (NMRA)

Kategoria

Healthcare
Historia ceny akcji dla Neumora Therapeutics, Inc. Common Stock (NMRA)
Najwyższa cena zamknięcia: $1.35 dnia 2026-09-01

Najniższa cena zamknięcia: $12.50 dnia 2023-09-01
Historia cen akcji firmy Neumora Therapeutics, Inc. Common Stock od 2023 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 4.72%
2025 -81.20%
2024 -26.84%
2023 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $551.00 37.41%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.05K 48.04%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $149.04 516.12%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.21 -10.03%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.53 8.46%
CH